Jaguar Health (JAGX) Cost of Revenue (2015 - 2026)

Jaguar Health (JAGX) has 12 years of Cost of Revenue data on file, last reported at $1.2 million in Q1 2026.

• On a quarterly basis, Cost of Revenue rose 124.85% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $4.4 million, a 116.52% increase from a year earlier, with the FY2025 full-year figure at $3.8 million, up 93.04% from the prior year.
• Cost of Revenue for Q1 2026 stood at $1.2 million, down from $2.2 million in the prior quarter.
• Over the last five years, Cost of Revenue for JAGX reached as high as $2.2 million in Q4 2025 and fell as low as $345000.0 in Q1 2023.
• Historically, Cost of Revenue has averaged $643705.9 across 5 years, with a median of $515000.0 in 2025.
• Across the five-year window, Cost of Revenue slumped 31.33% in 2022 and surged 294.97% in 2025, its largest moves.
• Year by year, Cost of Revenue stood at $495000.0 in 2022, then surged by 38.79% to $687000.0 in 2023, then decreased by 18.92% to $557000.0 in 2024, then jumped by 294.97% to $2.2 million in 2025, then plunged by 47.36% to $1.2 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $1.2 million in Q1 2026, $2.2 million in Q4 2025, and $532000.0 in Q3 2025.